Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rapid7 Advances 2026 PACT Partner Program to Strengthen Partner Led Go-to-Market and Profitability
-
Personal AI’s Memory-Based Small Language Models Deliver Hyper-Personalized Experiences on Comcast’s AI Grid, Powered by NVIDIA
-
HNL Lab Medicine Expands Access to Diagnostic Testing with New Wilkes-Barre Patient Service Center
-
UPDATE: ARKO Petroleum Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on March 30, 2026
-
VisionWave Subsidiary SolarDrone Acquires Controlling Interest in Junko Solar and Appoints Industry Executive as CEO
-
zSpace, Inc. Announces Additional $4.3 Million Senior Secured Convertible Note Issuance
-
Youxin Technology Ltd Completes Strategic Asset Acquisition in Hainan Free Trade Port to Accelerate International Market Expansion
-
Academy Sports + Outdoors Reports Fourth Quarter and Fiscal 2025 Results
-
Rocket Doctor AI Announces $2.049 Million Gross Proceeds from Warrant Exercises
-
GitGuardian Reports an 81% Surge of AI-Service Leaks as 29M Secrets Hit Public GitHub
-
TON Strategy Company Sets Fourth Quarter and Full Year 2025 Conference Call for Tuesday, March 31, 2026 at 9:00 a.m. ET
-
Xsolis Demonstrates Measurable ROI for AnMed Through AI-Enabled Utilization Management
-
Gency AI raises $20 million to build a sovereign advertising network powered by AI and blockchain consensus
-
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
-
Former Peloton and Equinox Design Leader Cecilia Farooqi Joins Noom as Head of Product Design
-
Genius Group CEO Roger Hamilton Buys 300,000 Company Shares on the Open Market
-
Pacvue and Reddit Announce Partnership to Bring Reddit Ads into Pacvue’s Commerce Operating System
-
Haitian Immigrant’s Journey of Love and Consequences in FOUND -- Just Published!
-
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Pa
-
ISG Names Angelic Gibson Chief Product and Technology Officer
-
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
-
Abacus Global Management to Participate in the 38th Annual Roth Conference
-
Byrna Technologies To Attend 38th Annual ROTH Conference
-
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
-
Decisions of the annual general meeting of shareholders of TKM Grupp AS 17th of March 2026
-
Admission of Further Securities to Trading
-
TFTIOR Expands Importer of Record Operations for Data Center and Telecom Infrastructure Deployments
-
Mythic® Selects memBrain™ Technology from Silicon Storage Technology® for its Next Generation of Ultra-Low-Power Analog Processing Units
-
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
-
HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
-
Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
-
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
-
Cycurion, Inc. Statement Regarding Unauthorized Press Release, Fabrication of Investor Relations Contact, and Related Market Activity – Litigation Counsel Engaged to Address Short Selling and Manipu
-
Fusemachines to Participate in the 38th Annual ROTH Conference
-
Neuroscale AI Secures $540,000 DoD SBIR Phase II (D2P2) Award to Advance Secure Multimodal AI for Federal Decision-Making
-
Form 8.3 - Picton Property Income Limited
-
Form 8.3 - Life Science REIT Plc
-
Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members
-
Form 8.3 - LondonMetric Property Plc
-
Form 8.3 - British Land Co plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
-
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico
-
POET Technologies and Lessengers Expand Partnership to Deliver 1.6T 2×DR4 Optical Transceivers for AI Network Connectivity
-
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
-
Xtract One Chosen by Morgan County Schools for Amplified Security at District’s High School Campuses
-
SL Green Realty Corp. to Release First Quarter 2026 Financial Results after Market Close on April 15, 2026
-
Xsolla SPAC 1 Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 18, 2026
-
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
